Object. The authors examined whether delayed treatment with Mg ϩϩ would reduce brain infarction and improve electrophysiological and neurobehavioral recovery following cerebral ischemia-reperfusion.
erebral stroke is a potential complication following CA revascularization procedures. Ischemia induces neuronal depolarization that removes the voltagedependent Mg ϩϩ blockade from NMDA receptors and renders endogenous glutamate neurotoxic. 6, 32, 45 Several antagonists of NMDA receptors have been found to decrease stroke lesions in animal models of ischemia, 19, 44 but at clinically active doses they usually produce sedation, respiratory depression, and cardiovascular and severe psychomimetic side effects in humans. 3, 24 As opposed to many experimental agents, Mg ϩϩ offers the advantage of already being used clinically without major side effects. It has also been proposed that the systemic adverse effects caused by NMDA antagonists may be greatly reduced and neuroprotective efficacy greatly enhanced, when Mg ϩϩ is administered directly via a proximal intraarterial infusion into the target organ. 13, 20 Magnesium ion can readily cross the blood-brain barrier to bind specific receptors in the brain. 8, 9 It prevents excitotoxicity in blocking various subtypes of Ca ϩϩ and NMDA channels and has proved to be neuroprotective in vitro and in vivo. 7, 21, 22, 38, 39 Marinov, et al., 20 showed that pretreatment with Mg ϩϩ reduces brain infarction following transient MCA occlusion. 20 They stated that the neuroprotective action of Mg ϩϩ is robust, dose dependent, and strongly related to the duration of ischemia. More recently, Mg ϩϩ has been demonstrated to preserve energetic metabolism and to attenuate glutamate release during cerebral ischemia and early reperfusion periods in a gerbil model of transient ischemic stoke. 18 Alternatively, we have shown that pretreatment with Mg ϩϩ protects the brain against permanent focal cerebral ischemia. 13 In a delayed treatment paradigm, intravenous administration of Mg ϩϩ was shown in rats to offer a window of opportunity that extends up to 6 hours following embolic stroke, a model closer to permanent focal cerebral ischemia. 43 Taken together, it is evident that Mg ϩϩ has the ability to modulate cerebral bioenergetics during ischemia-reperfusion and, therefore, offers neuroprotection against both permanent and transient focal cerebral ischemia. These studies further indicate that delayed reperfusion events, rather than the severity of an ischemic insult, may actually determine the in vivo neuroprotective actions offered by Mg ϩϩ against cerebral ischemia-reperfusion. Delayed reperfusion comes with massive production of reactive O 2 and N 2 species, which potentiate ischemic brain injury. 12, 36 Initial evidence from a study of in vitro ischemia has shown that Mg ϩϩ reduces damage to hippocampal CA1 neurons for up to 24 hours of ischemia-reperfusion. 37 Lacking to date have been in vivo experimental data verifying the neuroprotective potency of delayed Mg ϩϩ treatment following cerebral ischemia-reperfusion. Nevertheless, increasing evidence indicates that time lag of treatment, delayed reperfusion events, and potential adverse effects, particularly with regard to intravenous administration of Mg ϩϩ , may substantially hamper the translation of beneficial effects resulting from some in vivo experimental stroke models 13, 18, 20, 40, 43 to other in vivo experimental stroke models 47 and to clinical neuroprotective efficacy in human beings. 29 This has prompted us to assess whether delayed Mg ϩϩ treatment, in the form of an intracarotid infusion given at an early reperfusion time, would reduce brain infarction and improve electrophysiological and functional neurobehavioral outcomes, the most important clinical endpoints, following cerebral ischemic-reperfusion.
In this study we therefore examined whether brain infarction and electrophysiological and neurological behavior outcomes could be protected by a delayed intracarotid administration of Mg ϩϩ in rats subjected to 90 minutes of MCA occlusion followed by 72 hours of reperfusion. Additionally, we compared spatial and temporal changes in lCoBF between Mg ϩϩ -treated animals and controls. Finally, we sought to determine which anatomical structure (cortex or striatum) of the ischemic MCA territory would be better salvaged by Mg ϩϩ in the model.
Materials and Methods
All procedures that we performed were approved by the Subcommittee on Research Animal Care of the University Medical Center, whose standards meet the guidelines of the National Institutes of Health (Guide for the Care and Use of Laboratory Animals).
Animal Preparation, Anesthesia, and Monitoring
Male Sprague-Dawley rats, each weighing between 250 and 300 g, were supplied by the University Laboratory Animal Center and were allowed free access to food and water before and after surgery. Anesthesia was induced in these animals with a mixture of 1 to 2% halothane in 70% N 2 O/30% O 2 . During surgery, the rats' body temperatures were maintained at 37 Ϯ 0.5˚C by using a thermostatically controlled heating blanket and a rectal probe (Harvard Apparatus, South Natick, MA). The right femoral artery was cannulated for measuring arterial blood gas, glucose, hematocrit, heart rate, and blood pressure levels.
Experimental Model
Focal cerebral ischemia was induced by intraarterial suture occlusion of the proximal right MCA. 13, 14, 16 Briefly, with the aid of an operating microscope, we exposed the bifurcation of the right common CA. A No. 4-0 nylon suture, whose tip had been rounded by heating over a flame and subsequently coated with silicone (Merck KGaA, Darmstadt, Germany), was advanced 17.5 to 19 mm from the external CA into the internal CA until the suture tip occluded the origin of the MCA. After closure of the operative sites, the animals were allowed to awaken from anesthesia and were temporarily transferred to a cage with a heating lamp (ambient temperature ~ 26 Ϯ 1˚C). During another brief period of anesthesia, the suture was gently removed at 90 minutes of MCA occlusion. Reperfusion was confirmed by an improvement in the ipsilateral lCoBF at a defined area of the ischemic core cortex to approximately 50% of baseline after an initial decrease to approximately 20% of baseline caused by MCA occlusion, as determined by LDF (Laserflo BMP 2 ; Vasamedics, St. Paul, MN). After the surgical procedures, the animals were kept in a cage containing a heating lamp, monitored for 4 hours, and then transferred to their home cages (ambient temperature ~ 24 Ϯ 1˚C).
Magnesium sulfate (Sigma Chemical Co., St. Louis, MO) was dissolved in saline. A fresh drug solution was prepared shortly before its aministration. Each animal was given an intracarotid infusion containing either Mg ϩϩ (750 mol/kg, 12 rats) or vehicle (saline, 11 animals), over a 20-minute period starting at the initiation of reperfusion (that is, 90-110 minutes after onset of ischemia). The dose of Mg ϩϩ was based on the pharmacokinetic study of exogenous Mg ϩϩ in rodents and on findings from neuroprotective dose-response studies of Mg ϩϩ in a rat model of transient focal cerebral ischemia. 10, 20 Initial findings indicated that delayed treatment with Mg ϩϩ conferred neuroprotection against cerebral ischemia-reperfusion; however, it also induced modest hypothermia, attenuating postischemic hyperthermia. Given that hypothermia is a pheneomenon well known to protect against ischemic brain damage, we also included an additional set of animals that received vehicle (saline, eight rats) at the beginning of reperfusion. These animals were used to clarify whether Mg ϩϩ -induced neuroprotection would be attributed to its attenuating effect on postischemic hyperthermia. These animals' core temperatures were adjusted as closely as possible to temperatures observed in the Mg ϩϩ -treated animals by externally applying alcohol two consecutive times during the first 2 hours of reperfusion and then twice daily, at 8-hour intervals, after 24 hours of reperfusion. These animals were transferred to a cage with a small ventilating fan, which maintained the ambient temperature at approximately 22 Ϯ 1˚C, after 24 hours of reperfusion.
Monitoring of lCoBF
Laser Doppler flowmetry was used to obtain lCoBF measurements.
14, 16 The scalp of each animal was incised along the midline, and two 1.5-mm diameter areas in the bilateral parietal bones, 0.5 mm posterior and 7 mm lateral to the bregma, were thinned using a dental drill for placement of the LDF probes (model P436). The region was located on the SII, which was close to the core of the infarction caused by MCA occlusion on the operated side. Another 1.5-mm-diameter region in the right parietal bone, 2 mm posterior and 2.5 mm lateral to the bregma, was thinned for additional lCoBF measurements. This region is located on the posterior medial portion of the SI, which has been identified as a representative ischemic penumbral area in the model, based on the rat brain atlas and on data from previous studies on the measurements of cerebral blood flow. 25, 33 The lCoBF was serially measured before and during MCA occlusion and again 40 minutes after onset of reperfusion. The lCoBF data are expressed as percentages of baseline values.
Somatosensory Evoked Potential Recordings
Before the ischemic insult and again following a reperfusion period lasting between 70 and 72 hours, each animal was anesthetized and placed in a cage (60 ϫ 45 ϫ 45 cm) constructed of aluminum columns and copper meshes. The animal's head was fixed in a stereotactic frame that was adjusted so that the surface of the skull was level between the bregma and lambda. The cranium was then exposed to create two 1.5-mm-diameter holes drilled above the SI for each hemisphere. Appropriate stereotactic coordinates were measured from the bregma and from the midline (Ϫ0.5 and Ϫ2 mm in the anteroposterior direction for the forepaw receptive field and 4 and 2.5 mm laterally for the hindpaw receptive field). 2, 16 On exposure of the cortex, the dura mater was gently removed and the surface of the cortex was covered with warm saline. A metal microelectrode (impedance 500 kW at 1000 Hz) was positioned 0.5 mm below the cortical surface. Signals were filtered with band-pass (10-to 2000 Hz) and notch (60-Hz) filters and were recorded digitally on a computer by using associated software (Medelec Synergy Suite EMG/ EP; Oxford Instruments, UK). The somatosensory stimuli consisted of transcutaneous electrical stimulation (3 mA direct current, 1-msec duration, 1 Hz) of the fore-and hindpaws contralateral to the side of recording. A current stimulator and isolation unit constantly produced electrical pulses, which were delivered to the intraparenchymal needle electrode placed in the contralateral sensory cortex. Averaged records of at least 20 evoked potentials were computed online and stored on a computer disk. A custom-made software analysis provided measures of latency and field potentials. All SSEPs that had recognizable waveforms of the first positive (P 1 ) and first negative (N 1 ) peaks were used for latency and amplitude measurements. The amplitude was defined in terms of the difference between the P 1 and N 1 peaks.
Neurobehavioral Testing and Body Weight Measurements
Body weight measurements were obtained daily. A neurological evaluation was conducted before and after the ischemia-reperfusion insult and on a daily basis up to 3 days after reperfusion by two observers unaware of the treatment protocol. Two neurological grading systems were used: 1) a sensorimotor grading scale modified from that previously published by Belayev, et al., methods 1 which included five scores (0-4) for forward and sideways visual placement tests of the affected forelimb and five scores (0-4) for motor outcome; 13, 14, 16 and 2) a neurobehavioral grading scale developed by Clark and colleagues 4 for rodents with scores ranging from 0 to 28.
15,16

Planned Death of the Animals and Quantification of Ischemic Damage
The animals were first anesthetized and then killed after 72 to 74 hours of survival. Their brains were rapidly removed, cut into 2-mm coronal sections by using a rat brain matrix (RBM 4000C; ASI Instrument, Inc., Warren, MI), and stained according to the standard 2,3,5-triphenyltetrazolium chloride method. 13, 14, 16 Video images of coronal sections in each animal were obtained using a color chargedcouple device camera (Power HAD, model DXC-390 3 CCD system; Sony, Tokyo, Japan) equipped with a Micro-Nikon 55-mm f/ 2.8 lens. Areas of each brain were traced and measured using a computerized image analyzer (MCID Elite; Imaging Research, Inc., Ontario, Canada). Calculated infarct areas were compiled to determine the infarct volume in each brain (measured in cubic millimeters). Infarct volumes were expressed as a percentage of the contralateral hemispherical volume by using an "indirect method" (area of intact contralateral [left] hemisphere minus area of intact region of the ipsilateral [right] hemisphere) to compensate for the formation of edema in the ipsilateral hemisphere. The ipsilateral brain edema was determined by the summation of the volume increments of the right hemisphere on each brain section, relative to the corresponding volume of the left hemisphere, and was expressed as a percentage index relative to the volume of the left hemisphere. In addition, individual cortical and striatal infarct sizes were separately calculated.
Statistical Analysis
Neurobehavioral scores were expressed as medians Ϯ 95% confidence intervals and were analyzed by performing nonparametric tests for independent groups, that is, the Kruskal-Wallis test and the Mann-Whitney U-test. Other data were expressed as means Ϯ SEMs. A paired Student t-test was used to evaluate the response to a change in conditions, and a one-way analysis of variance with the Fisher protected least-significant difference post hoc comparison was used to evaluate differences between groups. Temperature, lCoBF, and SSEP values were analyzed among groups at each sampling time and location by performing repeated analyses of variance, followed by Fisher protected least-significant difference post hoc comparisons. A probability value less than 0.05 was selected for statistical significance.
Results
Throughout the course of the experiments, three animals (10%) died before completing the recovery protocol and were excluded from the analysis; two of the animals were in the vehicle-injected group and the third was in the Mg ϩϩ -treated group. Animals subjected to transient MCA occlusion invariably exhibited spontaneous hyperthermia. 34 Their core temperatures reached 37.6 to 38.7˚C within 1 hour, remained high during the first 24 hours, and then gradually subsided. Relative to the vehicle-injected controls, the Mg ϩϩ -treated animals had a significantly reduced level of core temperatures, by 0.8˚C during the early reperfusion period. This temperature-lowering effect offered by Mg ϩϩ was transiently lost during the 1st day, but reappeared between 48 and 72 hours of reperfusion (Fig. 1A) . The postischemic core temperature, however, did not differ significantly at each sampling time interval between Mg ϩϩ -treated animals and temperature-adjusted controls. The other physiological parameters of the animals were kept within normal physiological limits during the course of experiments and did not differ significantly among the three study groups (Table 1) .
Before the ischemia-reperfusion injury, stable SSEP waveforms containing two positive peaks and one intervening negative peak were consistently recorded after individual fore-and hindpaw stimulations ( Fig. 2A-D , AЈ-DЈ and I-L). The amplitude between the P 1 and the N 1 peaks and the P 1 latency did not differ significantly among the three study groups (Table 2) . At 72 hours after onset of reperfusion, significantly depressed SSEPs were recorded from the ischemic fore-and hindpaw cortical fields of both groups of vehicle-treated controls and the P 1 -N 1 amplitude decreased to 18 to 20% and 26 to 28% of baselines, respectively (p Ͻ 0.001; Table 2 and Fig. 2E , F, EЈ, and FЈ). These amplitudes did not differ significantly between the two groups of vehicle-injected animals, although Mg ϩϩ significantly enhanced the P 1 -N 1 amplitude of the SSEPs recorded from the ischemic fore-and hindpaw cortical fields, by 22 to 24% and 38 to 40% of baselines, respectively (p Ͻ 0.005 and p Ͻ 0.001; Table 2 and Fig. 2M and N) , relative to the two control groups.
Following 72 hours of reperfusion, animals in all three study groups displayed contralateral electrophysiological diaschisis, as indicated by a reduction in the P 1 -N 1 amplitudes measured in SSEPs recorded postischemia at the contralateral intact hindpaw cortical field, relative to their baseline values (p Ͻ 0.05; Table 2 and Fig. 2H , HЈ, and P). Additionally, temperature-adjusted controls and Mg ϩϩ -treated animals had prolonged P 1 latencies in the SSEPs recorded from the ischemic forepaw and hindpaw cortical fields (p Ͻ 0.01; Table 2 and Fig. 2EЈ, FЈ, M and N) , compared with their baseline values. These postischemic P 1 latencies of the ischemic cortical fields were, however, not significantly different among the three study groups. Moreover, the statistical analysis indicated that the amplitude and latency of the SSEPs recorded at 72 hours postischemia after individual right fore-or hindpaw stimulations were not significantly different among the three study groups (p Ͼ 0.05; Table 2 ).
The ipsilateral lCoBF recorded at the SII and the SI abruptly decreased to 15 to 18% and 36 to 40% of baselines, respectively, following onset of MCA occlusion. The decreased lCoBF values at the SII and SI subsequently im-proved to 48 to 50% and 78 to 92% of baselines, respectively, after the initiation of reperfusion. In contrast, the contralateral lCoBF did not significantly change over time during the course of the experiments. Before and during the ischemic insult, recordings of lCoBF did not differ significantly among the three groups of animals ( Fig. 1B-D ; p Ͼ 0.05). The Mg ϩϩ or mild temperature adjustments did not affect lCoBF values recorded either at the ipsilateral SI or SII or at the contralateral SII, as assessed within 40 minutes after treatment ( Fig. 1B-D ; p Ͼ 0.05).
Transient MCA occlusion resulted in large ipsilateral cortical and striatal infarcts that were reproducible but variable in size. None of the three groups of animals displayed any hemorrhagic transformation after death. The animals that received an intracarotid injection of Mg ϩϩ demonstrated a significant reduction in brain infarct volumes by 41 to 46% (p Ͻ 0.01), but not in the index of ipsilateral brain swelling (p Ͼ 0.05), compared with the two groups of vehicle-injected controls (Fig. 3A and B) . Cortical and striatal infarction lesions were reduced by 40 to 45% and 30 to 40%, respec-
FIG. 1. Line graphs demonstrating the effect of Mg
ϩϩ (750 mol/kg) on core temperature (A) and ipsilateral (B and C) and contralateral (D) lCoBF after MCA occlusion. Transient MCA occlusion induced marked spontaneous hyperthermia in rats, and delayed treatment with Mg ϩϩ (750 mol/kg in 11 rats), administered by an intracarotid infusion starting 1.5 hours after MCA occlusion (arrow), induced mild hypothermia compared with vehicle (saline)-injected animals (nine rats) (⌬). This temperature-lowering action was not significantly different when compared with the temperature-adjusted vehicle-injected control animals (eight rats). The temperature data are represented as mean degrees centrigrade Ϯ SEMs. *p Ͻ 0.05, when compared with values obtained in temperature-adjusted control animals. Before ischemia-reperfusion, the lCoBF did not differ significantly among the three study groups, and Mg ϩϩ (750 mol/kg) did not affect the lCoBF either at the ipsilateral ischemic core (B) or penumbral (C) cortices, or at the contralateral cortex (D) within 40 minutes of administration. The lCoBF data are presented as means Ϯ SEMs, which represent percentage changes relative to baseline values. Table 3 ).
tively, in the Mg
Discussion
This study confirmed that delayed treatment with Mg ϩϩ was neuroprotective and could reduce both cortical and striatal infarctions induced by transient MCA occlusion. Additional novel findings were that Mg ϩϩ improved neurobehavioral and electrophysiological outcomes in the model of cerebral ischemia-reperfusion, even when it was initiated as late as 90 minutes after onset of an ischemic insult. This neuroprotection cannot be accounted for by changes in hemodilution (as measured by the blood hematocrit levels), arterial blood pressure, heart rate, or differences in lCoBF because these were not significantly different when compared among the three study groups. Findings of previous * Physiological data obtained from control and Mg ϩϩ -treated animal groups are represented as the means Ϯ SEMs. Physiological parameters were normal and did not differ significantly among the three study groups. Abbreviations: Gluc = blood glucose; Hct = hematocrit; HR = heart rate; MABP = mean arterial blood pressure; temp = temperature. pharmacodynamic studies have indicated that systemic administration of Mg ϩϩ may lead to a dose-dependent decrease in both arterial blood pressure and heart rate. 13, 31 In this study, however, we found that the influence of an infusion of Mg ϩϩ on these hemodynamic parameters is not significant. The exact reason for this difference is not clear but may be due to the slower infusion rate via the intracarotid route, which may show less cardiovascular response.
Animals subjected to MCA occlusion for 90 minutes exhibited poststroke hyperthermia and this occurred most prominently within the first 24 hours of reperfusion. Treatment with Mg ϩϩ , however, decreased the core temperature significantly by 0.8˚C 2.5 hours after MCA occlusion, compared with vehicle-treated animals. This Mg ϩϩ -induced temperature-lowering action was transiently obscured during the 1st day but reappeared during the subsequent 2 days. Interestingly, the neuroprotective potency of Mg ϩϩ has recently been linked to the presence of mild hypothermia in a rat model of global cerebral ischemia. 46 Nevertheless, our results indicate that, relative to the vehicle-injected animals, temperature-adjusted controls did not achieve significant neuroprotection seen in infarct volume reductions or improvements in neurobehavioral and electrophysiological outcomes. Although postischemic hyperthermia is a factor accelerating the maturation of brain damage, 11, 17, 34 it appeared that Mg ϩϩ -induced hypothermia might not be robust enough to confer effective neuroprotection in the model. Other mechanism(s) of action may actually underlie the neuroprotection actions observed with Mg ϩϩ following transient focal cerebral ischemia.
The two neurobehavioral scoring systems used in the current study are mainly designed to test postischemic sensorimotor integrity in rodents. 1, 4, [13] [14] [15] [16] Sensorimotor dysfunction is commonly observed in rats subjected to permanent and transient MCA occlusion but the mechanisms underlying sensorimotor dysfunction are not precisely known. Increasing evidence, however, has indicated that the efficacy of neuroprotectants, particularly with regard to functional recovery, is largely dependent on their ability to protect against both gray and white matter damage. 15, 23, 42 It has been proposed that the lack of NMDA receptors in axons may restrict functional protection mediated through an exclusive NMDA receptor blockade. 44 Magnesium ions, however, have many additional pharmacological properties, such as the ability to inhibit the deleterious importation of Ca ϩϩ into the intracellular space and to protect against oxidative radicals and their antiapoptotic effects, all of which have the potential to protect against ischemic white matter damage. 5, 26, 27 Nevertheless, this remains elusive and needs further evaluation.
Impairment of sensorimotor function may substantially reflect a change in electrophysiological function and may not necessarily reflect a change in total infarct volumes or their percentages. It is well documented that extensive connections exist between the motor cortex and sensory cortex and between the cortex and subcortex. 41 These structures are involved in the processing and integration of sensorimotor information. Thus, the beneficial effect on preserving more viable brain tissues in both ischemic penumbral cortex and striatum observed with Mg ϩϩ may be an important factor contributing to the improved electrophysiological and neurobehavioral functions observed here, because the SI and the medial caudoputamen ipsilateral to the MCA occlusion Before ischemia-reperfusion, stable SSEP waveforms containing a first positive wave (P 1 ), a first negative wave (N 1 ), and a second positive wave (P 2 ) were recorded after individual fore-and hindpaw stimulations (A-D, AЈ-DЈ and I-L). At 72 hours after the onset of reperfusion, severely depressed SSEPs were recorded from the ischemic fore-and hindpaw cortical fields in both groups of vehicle-injected animals (E, F and EЈ, FЈ) and transcallosal electrophysiological diaschisis in the SSEPs recorded at the contralateral hindpaw cortical field were evident (H and HЈ). The depressed electrophysiological responses obtained postischemia were not significantly different, when a comparison was made between vehicle-injected controls and vehicle-injected temperature-adjusted controls. Treatment with Mg ϩϩ , however, significantly improved the amplitudes of the SSEPs recorded from both ischemic fore-and hindpaw cortical fields (M and N), although it did not affect transcallosal electrophysiological diaschisis (P) following ischemia-reperfusion.
are two representative ischemic penumbral regions following cerebral ischemia-reperfusion. 25 More important, Mg ϩϩ delivers a beneficial effect by preserving cerebral bioenergetics during ischemia and early reperfusion periods. 18 The postischemic bioenergetic level is a key factor determining the electrophysiological recovery recorded at cortical fields at risk of infarction. 30 Thus, the beneficial potential of Mg ϩϩ to prevent the depletion of adenosine triphosphate in the ischemic brain may also be one of the mechanisms underlying improved electrophysiological outcome, as observed here.
It is worthwhile to pursue studies of Mg ϩϩ as a neuroprotectant. Reasons for this include its posttreatment protection of the brain from infarction induced by transient MCA occlusion, as observed in this study, its consistent reductions in infarction volume and a wide therapeutic window of opportunity also reported in models of permanent and embolic MCA occlusion; 13, 43 and its marked reduction in systemic adverse effects. It should be noted that the postinsult administration of Mg ϩϩ within 12 hours after symptom onset failed to show efficacy in a clinical trial of ischemic stroke, although it may be helpful for lacunar strokes. 28 The exact reason for this translation failure is not currently clear. It is possible that prolonged ischemia plus delayed spontaneous reperfusion events may have caused a fundamental change in NMDA-activated ion channels and other molecular events such that Mg ϩϩ is no longer able to block the succession of ischemic cascades, which subsequently causes irreversible neuronal damage and eventually neuronal death. Nevertheless, promising results in preliminary clinical studies support the validity of testing the efficacy of early Mg ϩϩ administration, despite the fact that these studies have comprised very few patients. 29, 35 Although no neuroprotectant has been proven benefi- cial in the treatment of focal ischemic stroke in human beings, several currently available interventions have shown promising results in preliminary clinical trials. In particular, Mg ϩϩ offers an attractive potential therapy for stroke, because it is widely available, inexpensive, familiar to many clinicians, and can potentially be used by paramedics very early after onset of the insult. 28 The results in the present study, combined with data we have previously reported, 13 support the notion that Mg ϩϩ may have potential as an adjuvant therapy of intraarterial thrombolytic intervention for patients with ischemic stroke. It may also be worthwhile to investigate Mg ϩϩ further for its possible applicability in the field of CA revascularization, especially for those patients at risk of developing an ischemic stroke due to the poor vascular plasticity of the posterior communicating artery. Additional studies are needed, however, to decipher the molecular events through which Mg ϩϩ leads to neuroprotection of function, as observed here. Additional studies are also needed for evaluating the crucial therapeutic window of Mg ϩϩ and for verifying its potential benefit when combined with thrombolytic intervention (that is, extending the therapeutic window and/or reducing the rate of hemorrhagic transformation) in ischemic brain injury.
Conclusions
Delayed intraarterial administration with Mg
ϩϩ at the initiation of reperfusion both enhances electrophysiological and neurobehavioral outcomes and reduces cortical and striatal infarction after cerebral ischemia-reperfusion. This neuroprotection cannot be attributed to its attenuating effect on postischemic spontaneous hyperthermia. Because Mg ϩϩ offers the advantage of already being used clinically, it is worthwhile to investigate it further to determine its potential benefits for those patients who will undergo carotid endarterectomy and for possible applications for patients suffering from ischemic stroke.
